...
首页> 外文期刊>Molecular medicine reports >Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease
【24h】

Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease

机译:RG1通过抑制成内质网胁迫介导的C-6月N-末端蛋白激酶凋亡途径在阿尔茨海默病的大鼠模型中表现出神经保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

The neuroprotective agents currently used to treat Alzheimer's disease (AD) often only target one aspect of the disease process. Therefore, identifying effective drug targets associated with the pathogenesis of AD is critical for the production of novel AD therapeutic strategies. The present study aimed to investigate the underlying mechanisms of the neuroprotective effects of Rg1 on a rat model of AD. A double transgenic beta-amyloid (A beta) precursor protein/PS1 rat model was established, which co-expressed mutations associated with AD. A beta plaques and neurofibrillary tangles (NFTs) were detected by immunohistochemistry. The detection of the protein expression levels of caspase-3 and terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling (TUNEL) staining were used to determine the level of apoptosis in the brain tissue. The expression levels of the endoplasmic reticulum (ER) stress biomarker, glucose-regulated protein 78 (Grp78), and the mitochondrial apoptosis biomarkers, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax), were analyzed by western blotting. Furthermore, the expression of the proteins associated with the ER stress unfolded protein response (UPR) was determined, in order to examine the levels of ER stress. The mRNA expression of downstream genes of UPR were also detected by reverse transcription-polymerase chain reaction. The protein expression levels of the apoptosis-associated phosphorylated-c-Jun N-terminal protein kinase (p-JNK), caspase-12 and cAMP response element-binding transcription factor homologous protein were determined by western blotting. The results of the present study indicated that the accumulation of NFTs and A beta plaques was significantly decreased in the Rg1-treated AD rats, compared with untreated AD rats. The expression of caspase-3 and the number of TUNEL-positive cells were also significantly decreased in the Rg1-treated rats, as compared with the AD rats. Furthermore, treatment with Rg1 significantly reduced the expression of Grp78, and triggered inositol-requiring enzyme-1 (IRE-1) and phosphorylated protein kinase RNA-like ER kinase-associated ER stress. The IRE-1 UPR pathway downstream gene, tumor necrosis factor receptor-associated factor 2, was significantly decreased in rats treated with Rg1, compared with untreated AD rats. Furthermore, the activation of p-JNK was also inhibited when AD rats were treated with Rg1. In conclusion, Rg1 was shown to function as an important factor that inhibits the accumulation of NFTs and A beta via inhibition of the ER stress-mediated pathway. Blocking of this pathway was triggered by the IRE-1 and TRAF2 pathway, as a result of inhibition of the expression of p-JNK.
机译:目前用于治疗阿尔茨海默病(AD)的神经保护剂通常只针对疾病过程的一个方面。因此,鉴定与AD发病机制相关的有效药物靶标对于生产新的广告治疗策略至关重要。本研究旨在探讨RG1对广告大鼠大鼠模型的神经保护作用的潜在机制。建立双转基因β-淀粉样(β)前体蛋白/ PS1大鼠模型,其与AD相关的共同表达突变。免疫组化检测到β斑块和神经纤维缠结缠结(NFT)。使用Caspase-3和末端脱氧核苷酸转移酶介导的DUTP碎片末端标记(TUNEL)染色的蛋白质表达水平的检测用于确定脑组织中凋亡水平。内质网(ER)应激生物标志物,葡萄糖调节蛋白质78(GRP78)和线粒体凋亡生物标志物,B细胞淋巴瘤2(BCL-2)和BCL-2相关X蛋白(BAX)的表达水平,通过蛋白质印迹分析。此外,确定与ER应激展开蛋白质反应(UPR)相关的蛋白质的表达,以检查ER应激的水平。还通过逆转录聚合酶链反应检测UPR下游基因的mRNA表达。通过蛋白质印迹测定凋亡相关的磷酸化-C-Jun N-末端蛋白激酶(P-JNK),Caspase-12和CAMP响应元件结合转录因子同源蛋白质的蛋白表达水平。本研究结果表明,与未处理的Ad大鼠相比,RG1处理的Ad大鼠中NFT和β斑块的积累显着降低。与AD大鼠相比,在RG1处理的大鼠中,Caspase-3的表达和动脉阳性细胞的数量也显着降低。此外,用RG1治疗显着降低了GRP78的表达,并触发了肌醇的肌醇酶-1(IRE-1)和磷酸化蛋白激酶RNA样ER激酶相关的ER应激。与未处理的Ad大鼠相比,用RG1处理的大鼠肿瘤坏死因子受体相关因子2的肿瘤坏死因子受体相关因子2的肿瘤坏死因子受体相关因子2显着降低。此外,当用RG1处理AD大鼠时,也抑制了P-JNK的激活。总之,RG1被证明通过抑制ER应激介导的途径抑制NFT和β积累的重要因素。由于抑制P-JNK的表达,通过IS-1和TRAF2途径触发该途径的阻断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号